U.S. hedge fund veteran Jim Pallotta's family office plans to launch a new $200 million fund focused on blockchain and other cutting-edge technology sectors.
ChainCatcher news, according to Bloomberg, the family office of American hedge fund veteran Jim Pallotta is expanding its bets on decentralized finance (DeFi).
According to sources familiar with the matter, Pallotta’s Raptor Group is acting as a major backer to support a namesake venture capital firm in raising its second fund—which focuses on cutting-edge technology fields such as blockchain. The sources, who requested anonymity, said Raptor Digital plans to raise $200 million from the family office and institutions. After returning principal to existing investors in the first fund, the new fund will officially launch in the coming weeks. The 67-year-old Pallotta, a former executive at Paul Tudor Jones’ hedge fund, not only invested in Raptor Digital’s first fund, which raised $60 million in 2023, but that fund also received backing from a division of Abu Dhabi’s Mubadala. Boston-based Raptor Digital (formerly RW3 Ventures, also focused on AI investments) declined to comment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
